Croghan Bancshares, Inc. - CHBH

CHBH Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CHBH	0	-0.0	8.5	0.0	7.7	2.2	-24.6	-8.4	36.3	147.2
S&P 500	-1.3	-2.3	0.5	5.7	10.7	30.1	25.2	88.0	187.6	33142.5

Compare CHBH with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CHBH
name	Croghan Bancshares, Inc.
price	49.01
changes percentage	0
change	0
day low	49.01
day high	49.01
year high	50.25
year low	45
market cap	110128901
price avg 50	46.72
price avg 200	46.32
exchange	PNK
volume	3000
avg volume	803
open	49.01
previous close	None
eps	4.71
pe	10.41
earnings announcement	None
shares outstanding	2247070
timestamp	2024-11-15 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 34.0%

Overall Quarterly Financial Health: 77.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	41818000	44674000	-6.39
gross profit	53320000	44674000	19.35
gross profit ratio	1.28	1	27.50
research and development expenses	0	0	NaN
operating expenses	19600000	-25552000	176.71
interest income	47529000	39797000	19.43
interest expense	11427000	2129000	436.73
ebitda	14153000	18220000	-22.32
ebitdaratio	0.34	0.46	-25.70
operating income	22218000	19122000	16.19
operating income ratio	0.53	0.43	24.13
net income	10773000	14014000	-23.13
net income ratio	0.26	0.31	-17.88
eps	5.05	6.41	-21.22

Overall Score of Annual Income Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 42 million in 2023 from 45 million in 2022 representing a change of -6.39%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 20 million in 2023 from -26 million in 2022 representing a change of 176.71%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 14 million in 2023 from 18 million in 2022 representing a change of -22.32%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 11 million in 2023 from 14 million in 2022 representing a change of -23.13%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 5.05 in 2023 from 5.05 in 2022 representing a change of -21.22%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 53 million in 2023 from 45 million in 2022 representing a change of 19.35%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to 22 million in 2023 from 19 million in 2022 representing a change of 16.19%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	15208000	14798000	2.77
gross profit	15208000	14798000	2.77
gross profit ratio	1	1	0.00
research and development expenses	0	0	NaN
operating expenses	-12154000	0	NaN
interest income	13825000	0	NaN
interest expense	4735000	0	NaN
ebitda	3054000	2890000	5.67
ebitdaratio	0.2	0.2	2.83
operating income	27362000	14798000	84.90
operating income ratio	1.8	1	79.92
net income	2451000	2332000	5.10
net income ratio	0.16	0.16	2.27
eps	1.17	1.11	5.41

Overall Score of Quarterly Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 15 million in 2024Q3 from 15 million in 2024Q2 representing a change of 2.77%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 15 million in 2024Q3 from 15 million in 2024Q2 representing a change of 2.77%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to -12 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 3 million in 2024Q3 from 3 million in 2024Q2 representing a change of 5.67%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 27 million in 2024Q3 from 15 million in 2024Q2 representing a change of 84.9%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 2 million in 2024Q3 from 2 million in 2024Q2 representing a change of 5.1%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.17 in 2024Q3 from 1.17 in 2024Q2 representing a change of 5.41%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1120073000	1125763000	-0.51
total liabilities	1000416000	60500000	1,553.58
total equity	119657000	109070000	9.71
cash and cash equivalents	37358000	21020000	77.73
short term investments	0	330236000	-100.00
long term investments	23332000	330236000	-92.93
total current assets	61946000	355568000	-82.58
total non current assets	1095485000	362855000	201.91
total current liabilities	481864000	461959000	4.31
total non current liabilities	998471000	60500000	1,550.37
common stock	31328000	31328000	0.00
retained earnings	121718000	116205000	4.74
total debt	58500000	60500000	-3.31

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,120 million in 2023 from 1,126 million in 2022 representing a change of -0.51%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 1,000 million in 2023 from 60 million in 2022 representing a change of 1553.58%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 330 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 62 million in 2023 from 356 million in 2022 representing a change of -82.58%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 482 million in 2023 from 462 million in 2022 representing a change of 4.31%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Equity: Total Equity increased to 120 million in 2023 from 109 million in 2022 representing a change of 9.71%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 37 million in 2023 from 21 million in 2022 representing a change of 77.73%. This indicates an increase in available liquid assets.

  Retained Earnings: Retained Earnings increased to 122 million in 2023 from 116 million in 2022 representing a change of 4.74%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 58 million in 2023 from 60 million in 2022 representing a change of -3.31%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	1148203000	1122944000	2.25
total liabilities	1017803000	999932000	1.79
total equity	130400000	123012000	6.01
cash and cash equivalents	50818000	-32787000	254.99
short term investments	0	0	NaN
long term investments	312530000	0	NaN
total current assets	50818000	32787000	54.99
total non current assets	1097385000	1090157000	0.66
total current liabilities	0	0	NaN
total non current liabilities	0	999932000	-100.00
common stock	0	0	NaN
retained earnings	125829000	124593000	0.99
total debt	0	0	NaN

Overall Score of Quarterly Balance Sheet

0.83 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,148 million in 2024Q3 from 1,123 million in 2024Q2 representing a change of 2.25%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 130 million in 2024Q3 from 123 million in 2024Q2 representing a change of 6.01%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 51 million in 2024Q3 from -33 million in 2024Q2 representing a change of 254.99%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 51 million in 2024Q3 from 33 million in 2024Q2 representing a change of 54.99%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 126 million in 2024Q3 from 125 million in 2024Q2 representing a change of 0.99%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,018 million in 2024Q3 from 1,000 million in 2024Q2 representing a change of 1.79%. This indicates an increase in overall liabilities.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	16338000	-24781000	165.93
operating cash flow	14445000	17846000	-19.06
free cash flow	13186000	17180000	-23.25
capital expenditure	-1259000	-666000	-89.04
depreciation and amortization	1136000	1227000	-7.42
deferred income tax	-386000	261000	-247.89
stock based compensation	250000	188000	32.98
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-13193000	3000	-439,866.67
investments in property plant and equipment	-1259000	-666000	-89.04
net cash used for investing activites	27090000	-79082000	134.26
debt repayment	-2000000	43000000	-104.65
common stock issued	0	0	NaN
common stock repurchased	-2906000	-2661000	-9.21
dividends paid	-4878000	-4839000	-0.81
net cash used provided by financing activities	-25197000	36455000	-169.12
cash at end of period	37358000	21020000	77.73
accounts receivables	-274000	-707000	61.24
cash at beginning of period	21020000	45801000	-54.11

Overall Score of Annual Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 16 million in 2023 from -25 million in 2022 representing a change of 165.93%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -1 million in 2023 from -1 million in 2022 representing a change of -89.04%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 14 million in 2023 from 18 million in 2022 representing a change of -19.06%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 13 million in 2023 from 17 million in 2022 representing a change of -23.25%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2023 from 0 million in 2022 representing a change of 32.98%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2023 from -1 million in 2022 representing a change of 61.24%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -5 million in 2023 from -5 million in 2022 representing a change of -0.81%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0000000000
operating cash flow	0	0	NaN
free cash flow	0	0	NaN
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	125000	125000	0.00
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	0	NaN
net change in cash	0	0	NaN
cash at end of period	0	0	NaN
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	19.6	20.45	-4.14
net income per share	5.05	6.41	-21.27
operating cash flow per share	6.77	8.17	-17.11
free cash flow per share	6.18	7.86	-21.40
cash per share	17.51	160.76	-89.11
book value per share	56.08	487.54	-88.50
tangible book value per share	45.58	477.25	-90.45
shareholders equity per share	56.08	49.92	12.35
interest debt per share	32.78	28.66	14.34
market cap	98142518	122357704	-19.79
enterprise value	119284518	161837704	-26.29
pe ratio	9.11	8.73	4.34
price to sales ratio	2.35	2.74	-14.31
pocfratio	6.79	6.86	-0.91
pfcf ratio	7.44	7.12	4.50
pb ratio	0.82	1.12	-26.89
ptb ratio	0.82	1.12	-26.89
ev to sales	2.85	3.62	-21.26
enterprise value over ebitda	8.43	8.88	-5.11
ev to operating cash flow	8.26	9.07	-8.94
ev to free cash flow	9.05	9.42	-3.97
earnings yield	0.11	0.11	-4.16
free cash flow yield	0.13	0.14	-4.31
debt to equity	0.49	0.55	-11.86
debt to assets	0.05	0.05	-2.81
net debt to ebitda	1.49	2.17	-31.06
current ratio	0.13	0.77	-83.30
interest coverage	1.94	8.98	-78.35
income quality	1.34	1.27	5.29
dividend yield	0.05	0.04	25.68
payout ratio	0.45	0.35	31.13
sales general and administrative to revenue	0.45	0.37	22.72
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.02	0.02	0.15
capex to operating cash flow	0.09	0.04	133.55
capex to revenue	0.03	0.01	101.95
capex to depreciation	1.11	0.54	104.18
stock based compensation to revenue	0.01	0.0	42.06
graham number	79.82	84.88	-5.95
roic	0.1	0.09	10.98
return on tangible assets	0.01	0.01	-22.73
graham net net	-451.39	129.3	-449.10
working capital	-419918000	-106391000	-294.69
tangible asset value	97241000	1042767000	-90.67
net current asset value	-938470000	295068000	-418.05
invested capital	-386762000	-73772000	-424.27
average receivables	2156000	3958500	-45.53
average payables	0	0	NaN
average inventory	-11473500	-23115500	50.36
days sales outstanding	0	35.23	-100.00
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	10.36	-100.00
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.09	0.13	-29.93
capex per share	0.59	0.3	93.60

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.11 on 2023-12-31 from 8.73 on 2022-12-31, representing a change of 4.34%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.49 on 2023-12-31 from 0.55 on 2022-12-31, representing a change of -11.86%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio decreased to 0.13 on 2023-12-31 from 0.77 on 2022-12-31, representing a change of -83.30%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
CHBH
calendar year	2024	2024	NaN
revenue per share	7.25	7.05	2.86
net income per share	1.17	1.11	5.19
operating cash flow per share	None	None	NaN
free cash flow per share	None	None	NaN
cash per share	24.24	-15.62	255.13
book value per share	62.19	58.62	6.10
tangible book value per share	62.19	58.62	6.10
shareholders equity per share	62.19	58.62	6.10
interest debt per share	2.26	0	NaN
market cap	96747966.9	95591958.8	1.21
enterprise value	45929966.9	128378958.8	-64.22
pe ratio	9.87	10.25	-3.70
price to sales ratio	6.36	6.46	-1.52
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	0.74	0.78	-4.52
ptb ratio	0.74	0.78	-4.52
ev to sales	3.02	8.68	-65.19
enterprise value over ebitda	15.04	44.42	-66.14
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	0.03	0.02	3.85
free cash flow yield	None	None	NaN
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	-16.64	11.34	-246.67
current ratio	0	0	NaN
interest coverage	5.78	0	NaN
income quality	0	0	NaN
dividend yield	None	None	NaN
payout ratio	None	None	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	None	None	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	None	None	NaN
graham number	40.44	38.28	5.64
roic	0.17	0.1	73.48
return on tangible assets	0.0	0.0	2.79
graham net net	-461.16	-492.1	6.29
working capital	50818000	32787000	54.99
tangible asset value	130400000	123012000	6.01
net current asset value	-966985000	-967145000	0.02
invested capital	50818000	32787000	54.99
average receivables	0	0	NaN
average payables	0	0	NaN
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.02	0.02	-0.85
capex per share	None	None	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -0.85%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 9.87 on 2024-09-30 Q3 from 10.25 on 2024-06-30 Q2, representing a change of -3.70%. Indicating a decrease in the relative valuation of the company's stock.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 64.24 which is higher than current price 49.01, indicates the company may be undervalued.